Leave message
Can’t find what you’re looking for?
Fill out this form to inquire about our custom protein services!
Inquire about our Custom Services >>
| Cat. No. | Species | Product Description | Structure | Purity | Feature |
|---|---|---|---|---|---|
| GDF-H5118 | Human | Human GDNF / ATF / hGDNF Protein (E. coli), premium grade |  |
|
|
| GDF-M5245 | Mouse | Mouse GDNF / ATF Protein, His Tag (MALS verified) |  |
|
|
| GDF-H5219 | Human | Human GDNF / ATF / hGDNF Protein, premium grade |  |
|
|
Immobilized Human GDNF Protein, premium grade (Cat. No. GDF-H5219) at 2 μg/mL (100 μL/well) can bind Human GFR alpha-1, His Tag (Cat. No. GF1-H5224) with a linear range of 0.2-4 ng/mL (QC tested).
The purity of Mouse GDNF, His Tag (Cat. No. GDF-M5245) is more than 90% and the molecular weight of this protein is around 40-50 kDa verified by SEC-MALS.
| Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
|---|---|---|---|---|---|
| AAV2-GDNF | AMT-140; AB-1005 | Phase 2 Clinical | Lund University Foundation, National Institute Of Neurological Disorders And Stroke, Uniqure Biopharma Bv, Uc San Francisco | Parkinson Disease; Multiple System Atrophy | Details |
| NRO-1 | NRO-1; SI-01 | Phase 2 Clinical | Senju Pharmaceutical Co Ltd | Xerophthalmia | Details |
| AMT-130 | AAV5-miSNP15; AAV5-miSNP7; AMT-130; AAV5-miHtt12 | Phase 2 Clinical | Amsterdam Molecular Therapeutics, Uniqure | Huntington Disease | Details |
| AAV2-GDNF gene therapy (NINDS) | Phase 1 Clinical | National Institute Of Neurological Disorders And Stroke | Parkinson Disease | Details |
This web search service is supported by Google Inc.
A-Z
